ArticleBlood cancer journal2024

Flow cytometric analysis of erythroid precursors and mutational signatures of lower risk myelodysplastic syndromes identify responders to erythroid stimulating agents.

Marco G Raddi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.